Spt3 is a Saccharomyces cerevisiae transcription factor that is required in vivo for the transcription of a number of RNA polymerase II-transcribed genes. We report the cloning of the gene encoding the human homologue of Spt3, SUPT3H, and its initial functional analysis. The human and yeast Spt3 homologues share an overall identity of 30% that defines three conserved regions, suggesting possible functional domains. To determine whether SUPT3H is a true functional Spt3 homologue, we tested for complementation of an spt3⌬ mutation in yeast. While expression of the full-length SUPT3H is unable to complement an spt3⌬ mutation, expression of a human-yeast chimeric gene that contains 42% human sequences can partially complement an spt3⌬ mutation. These data suggest that the transcriptional control carried out by Spt3 has been conserved from yeast to human.
INTRODUCTION
The regulation of RNA polymerase II (pol II) transcription in eukaryotes is highly conserved from yeast to humans [for a review see Zawel and Reinberg (1995) ]. Conserved components include RNA polymerase II, the general transcription factors including TATA-binding protein (TBP), the TBP-associated factors (TAFs), components of the holoenzyme/mediator complex, and components required for regulation and maintenance of chromatin structure, such as the Snf/ Swi complex.
Recently, a complex in yeast important for transcription was identified and shown to contain several previously identified transcription factors, including the histone acetyltransferase, Gcn5, and several Spt and Ada proteins (Grant et al., 1997; Roberts and Winston, 1997) . This complex, SAGA (for Spt/Ada/Gcn5 acetylatransferase), was demonstrated to acetylate nucleosomal histones in vitro (Grant et al., 1997) . Genetic studies strongly suggest that SAGA contains other functions besides histone acetyltransferase activity (Horiuchi et al., 1997; Roberts and Winston, 1997) . Among the members of SAGA, human homologues for two of them, Gcn5 and Ada2, have been identified and shown to be functionally conserved (Candau et al., 1996) .
Among the other known components of SAGA, one of the best studied is Spt3. The SPT3 gene was initially identified by mutations that suppress the transcriptional defects caused by retrotransposon (Ty) insertion mutations in the promoter regions of the Saccharomyces cerevisiae HIS4 and LYS2 (Winston et al., 1984 (Winston et al., , 1987 . Subsequently, Spt3 was shown to be required for normal transcription of several genes in yeast, including Ty elements and genes encoding the mating pheromones a-factor and ␣-factor (Hirschhorn and Winston, 1988; Winston et al., 1984) . Other work has suggested that Spt3 is functionally and physically associated with TBP. First, null mutations in SPT3 cause a set of phenotypes extremely similar to a particular allele in SPT15, the gene that encodes TBP (Eisenmann et al., 1992) . Second, genetic studies demonstrated allele-specific interactions between particular spt3 and spt15 mutations (Eisenmann et al., 1992) . Finally, biochemical evidence suggests that Spt3, as part of the SAGA complex, associates with TBP (Eisenmann et al., 1992; Roberts and Winston, 1997) . More recent genetic analysis suggests that Spt3 functionally interacts with Mot1 and the general transcription factor TFIIA to specify TBP binding at certain promoters (Madison and Winston, 1997a) . Taken together, these studies suggest that Spt3 is required for one activity of SAGA that is critical for normal TBP function at particular promoters.
Recently Spt3 was demonstrated to be functionally conserved among different yeasts (Madison and Win- ston, 1997b). However, only one larger eukaryotic protein has been identified that has significant homology to Spt3, human TAF II 18 (Mengus et al., 1995) . It seemed unlikely that this human TAF is a functional homologue of yeast Spt3 since TAF II 18 shares greater overall size and sequence homology to another yeast protein, Fun81, which is likely to be its true yeast homologue (Dubois et al., 1987; Mengus et al., 1995) .
We describe here the identification and initial functional analysis of a human Spt3 homologue. The human gene, SUPT3H, was identified during positional cloning of the gene mutated in cleidocranial dysplasia (CCD), an autosomal skeletal disorder that is characterized by lack of clavicles, open sutures, and supernumerary teeth [Mundlos et al., 1995;  see also Online Mendelian Inheritance in man (OMIM) 119600]. The CCD locus had been previously mapped to the chromosomal region 6p21.1-p21.3 by disequilibrium linkage and deletion analysis (Mundlos et al., 1995) . The SUPT3H gene was subsequently discovered during the search for open reading frames in this region, although SUPT3H is not the gene mutated in CCD Otto et al., 1997) . To test whether SUPT3H is indeed a functional SPT3 homologue, human-yeast chimeras have been constructed, tested in yeast, and shown to complement partially an spt3⌬ mutation. These data suggest that Spt3 function has been partially conserved from yeast to human. While this work was in progress, SUPTH3 was also discovered to be in a complex closely related to the S. cerevisiae SAGA complex (Ogryzko et al., 1998) , strengthening the possiblity that the yeast and human proteins carry out similar roles in transcription.
MATERIALS AND METHODS
cDNA cloning of a human SPT3 gene. Several overlapping human-yeast artificial chromosomes (YACs) cover the CCD locus (Yu, Mundlos, and Olsen, unpublished results) . To obtain genomic DNA from these YACs, Alu-PCR was performed using the following conditions: 4 min at 94°C, and 34 cycles of 1 min at 94°C, 1 min at 54°C, and 2 min at 72°C (Breukel et al., 1990) . Partial sequencing of an Alu-PCR product from YAC 948G7 revealed a 20-nucleotide identity to the 5Ј end of the expression sequence tag (EST) clone 123089. EST 123089 (Accession No. T98541) was obtained from the MerckWashU EST Project and used as a probe to screen a Lambda ZAP human craniofacial library. Hybridization was performed in 50% formamide, 6ϫ SSC at 42°C and washing was carried out with three washes in 0.1ϫ SSC/0.1% SDS at 55°C. One positive clone (hJM1), containing a 1.8 kb insert, was identified. hJM1 was sequenced using an AmpliCycle Sequencing Kit (Perkin-Elmer, Inc.), and its 3Ј sequence overlapped with the 5Ј sequence of the EST 123089 clone by 600 bp. A computer BLAST search against GenBank sequences suggested that it was a novel gene with highest homology to the yeast SPT3 gene. This human clone (hJM1) was sequenced using an Applied Biosystems sequencer (Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School). The human gene has been designated SUPT3H, and its sequence has been deposited with GenBank (Accession No. AF064804).
Sequence alignment of the human and yeast Spt3 proteins. The amino acid sequences of human and yeast Spt3s were aligned using the Clustal method with the PAM250 residue weight table and the DNAStar MEGALIGN program.
Media, yeast strains, and genetic methods. Synthetic complete (SC) and synthetic defined media were prepared as described previously (Rose et al., 1990) . The yeast strains used for functional complementation are FY294 MATa spt3⌬202 his4-917␦ lys2-173R2 ura3-52 leu2⌬1 and FY631 MATa his4-917␦ lys2-173R2 ura3-52 leu2⌬1. Yeast strains were transformed by a lithium acetate procedure (Ito et al., 1983; Elble, 1992) , and transformants were selected on the appropriate SC medium.
Construction of full-length SUPT3H.
The pRS series of plasmids has been described previously (Christianson et al., 1992; Sikorski and Hieter, 1989) . The plasmids phJM and p123089 containing the 5Ј and 3Ј portions of the human SPT3 cDNA were used to construct a full-length SUPT3H cDNA. The 900-bp EcoRI insert from plasmid p123089 was excised and ligated into the pRS306 EcoRI site to create pJM199. To generate a full-length SUPT3H, the plasmid phJM1 containing the SUPT3H XhoI-XbaI fragment in pBluescript was cut with BstEII-XhoI, and the BstEII-XhoI fragment was ligated into the BstEII-XhoI sites in pJM199 to create pJM200.
Construction of human-yeast chimeric genes.
Human-yeast SPT3 chimeric plasmids are listed in Table 1 , and their construction is described below. In those constructs that contain the N-terminal human sequences, we used the methionine codon at position 83 to increase the chances of expressing a functional protein in S. cerevisiae. The N-terminal human C-terminal yeast SPT3 chimeras (plasmids pJM209, pJM202, pJM210, pJM235, and pJM203 and chimeras 1-5) were generated as follows. To generate the N-terminal human SPT3 portions of the chimeras, the 5Ј human SPT3 primer was synthesized with an SpeI site for subcloning, sequences encoding the initiator methionine, an HA-1 epitope tag, and the first 5 amino acid residues after the initiator methionine of the human gene. The 3Ј human SPT3 primer was synthesized with sequences encoding the C-terminal residues of the human portion of the chimera plus the first 5 amino acids of the N-terminal end of the yeast SPT3 portion of the gene to create an in-frame fusion between human and yeast sequences at this junction. The C-terminal yeast portions of the chimeras were generated as follows. 5Ј PCR primers to yeast SPT3 were chosen that overlapped with the amino acid residues incorporated into the N-terminal human SPT3 portion of the chimera. The 3Ј most yeast SPT3 primer contained a BamHI site and the last 5 amino acids of yeast Spt3 including the translation termination codon. The human and yeast portions of the chimera were PCRamplified, and the PCR products were phenol-extracted and digested with SpeI and BamHI and with a restriction enzyme that would cut uniquely in the common yeast sequences of the N-terminal human SPT3 portion and in the C-terminal yeast portion of the chimera. This generates an in-frame fusion of the 5Ј human portions and 3Ј yeast portions of SPT3 when ligated into the SpeI and BamHI sites of p425-MET25. The p425-MET25 plasmid has been described previously (Mumberg et al., 1994) .
N-terminal yeast C-terminal human SPT3 chimeras were created in a similar fashion and are listed in Table 1 (plasmids pJM204,  pJM205 , pJM206, pJM195, and pJM196 and chimeras 6 -10). Plasmid pJM198 is not a yeast human chimera but is a 3Ј terminal truncation of S. cerevisiae SPT3 containing a translation termination codon after residue 258 of the S. cerevisiae SPT3 sequence. Plasmid pJM198 was generated similarly to the yeast-human chimeras except that the 3Ј PCR primer contained a translation termination codon and a BamHI site for subcloning.
Extract preparation of strains expressing SPT3 homologues or human yeast SPT3 chimeras. All homologues and chimeras were expressed from the MET25 promoter on plasmid p425-MET25 in medium lacking methionine and leucine. For Western analysis, FY294, an spt3⌬ strain, or FY631, an SPT3 ϩ strain, were grown in SD medium supplemented with the appropriate amino acids. Ten-microliter cultures were grown overnight at 30°C to saturation and then diluted to 1 ϫ 10 6 cells/ml and grown to a density of 1-2 ϫ 10 cells/ml. Cultures were harvested, and extracts were prepared by washing once in ice-cold Buffer H consisting of 25 mM Tris, pH 7.4, 15 mM EGTA, 15 mM MgCl 2 , 1 mM DTT, 0.1% Triton X-100, 1 mM NaN 3 , 0.2 mM phenylmethylsulfonyl fluoride and then quick frozen in an ethanol-dry ice bath. Cells were disrupted by adding 250 l cold Buffer H to the cell pellet, adding glass beads to the meniscus, and vortexing at 4°C for 5 min. Another 200 l of Buffer H was added, the extract was vortexed briefly, and the supernatant was transferred to a clean tube. Extracts were spun for 10 min at 14,000 rpm in an Eppendorf microcentrifuge. The supernatant was removed to a fresh tube, and extracts were spun for 10 min more at 14,000 rpm at 4°C. Protein concentrations were determined with Bio-Rad Bradford reagent diluted 1:4 with water. BSA was used as a standard.
Western analysis. Extracts prepared from strains expressing SPT3 homologues were run on 12.5% SDS polyacrylamide gels. Following separation, proteins were transferred to Immobilon membrane (New England Nuclear) with a semidry electroblot apparatus (W.E.P. Co., Seattle, WA) using a transfer buffer consisting of 50 mM Tris, 28 mM glycine. Following transfer, even loading and transfer were verified by Ponceau S staining. Subsequently, membranes were blocked with 1% BSA, 1% milk (Carnation) in TBS (20 mM Tris, 137 mM NaCl, pH 7.6) for 45-120 min at room temperature or overnight at 4°C. A mouse monoclonal 12CA5 antiserum against the HA-1 epitope (Boerhinger Mannheim) was used at a dilution of 1:1000 in 1% BSA, 1% milk. Membranes were probed for 1 h at room temperature with rocking and then washed with agitation in 1ϫ TBS, 0.1% Tween for 45 min at room temperature with three changes of wash solution. Membranes were then incubated with a secondary goat anti-mouse antibody (Bio-Rad) conjugated to horseradish peroxidase at a dilution of 1:10,000 in 1% BSA, 1% milk with rocking for 1 h at room temperature. Membranes were then washed with agitation for 45-120 min in 1ϫ TBS, 0.1% Tween with three changes of wash solution. Western blots were developed using the ECL Detection System (Amersham) and exposed to autoradiographic film.
RESULTS

Isolation of Human SPT3 Sequences
Previously, CCD had been mapped to chromosome 6p21. To randomly amplify genomic DNA sequences from this region, Alu-PCR was performed using different YACs as templates and a YAC end primer and an Alu primer as primer pairs. PCR products from these Alu-PCRs were partially sequenced and compared against sequences in GenBank using the BLAST algorithm. One PCR sequence obtained from YAC 948G7 was found to share a 20-nucleotide identity to EST 123089. This partial overlap suggested that this EST might represent part of a novel gene from the CCD locus and thus might represent a candidate for the gene mutated in CCD. The complete cDNA was obtained by screening a human craniofacial cDNA library. From the complete cDNA the predicted amino acid sequence was deduced (Fig. 1) . A BLAST search of GenBank with this deduced amino acid sequence showed that this novel protein shared the greatest similarity to the yeast transcription factor Spt3. This homology suggested that this gene might be the human homologue of Spt3 and was designated SUPT3H.
The Alignment of the Human and Yeast Spt3 Proteins Reveals Three Conserved Regions
To determine the overall identity of the yeast and human Spt3 sequences, the deduced amino acid sequences were aligned (Fig. 2A) . The previously identified Schizo- saccharomyces pombe Spt3 was included in this alignment. The predicted human Spt3 protein is significantly longer than either the S. cerevisiae or the S. pombe proteins, with approximately 80 additional amino acids at the amino-terminal end that are not homologous to the yeast proteins. However, beginning with the methionine at position 83, human Spt3 shares over 40% similarity with the S. pombe Spt3 protein (Madison and Winston, 1997b) . The alignment reveals three conserved regions that may define three domains (Fig. 2B) . Region 1 shares homology with human TAF II 18. These three regions are also conserved among previously identified yeast homologues of Spt3 (Madison and Winston, 1997b) . In addition to the blocks of homology that can be seen, a number of residues that have been identified as important for Spt3 function are conserved in all homologues. The residue E240, altered in spt3-401, an allele-specific suppressor of the spt15-21 mutation, is conserved in all homologues (Eisenmann et al., 1992) . In addition, the residue M188, mutated in a dominant-negative spt3 mutation, is also conserved in all homologues (Madison and Winston, 1997b; Rose and Winston, unpublished results) . The high degree of sequence conservation suggests that the human gene is a true Spt3 homologue.
Functional Analysis of SUPT3H
To determine whether SUPT3H is a functional homologue of S. cerevisiae SPT3, we tested it for complementation of an spt3⌬ mutation. Previous analysis has shown that spt3⌬ mutations suppress the insertion mutations his4-917␦ and lys2-173R2. (Eisenmann et al., 1992) . To measure the function of SUPT3H in S. cerevisiae, we tested for complementation of these Spt Ϫ phenotypes as described under Materials and Methods. SUPT3H was expressed under the control of the S. cerevisiae MET25 promoter in a high-copy plasmid (Mumberg et al., 1994) . To measure protein levels, SUPT3H was modified to encode an HA1 epitope tag at its 5Ј end. S. cerevisiae Spt3 had been determined previously to be unaffected by an epitope tag at the N-terminus (Eisenmann et al., 1992) . Previous analysis of a number of similarly tagged yeast SPT3 homologues has shown that K. lactis and S. pombe SPT3 show full and partial complementation, respectively, of an spt3⌬ mutation (Madison and Winston, 1997b) . As shown in Fig. 4 , SUPT3H did not complement an spt3⌬ mutation. It also did not cause a dominant mutant phenotype when expressed in an SPT3 ϩ strain. Western analysis showed that SUPT3H is expressed in S. cerevisiae (data not shown) albeit at lower levels than HA-1 tagged S. cerevisiae Spt3 expressed from the same promoter. To increase our chances of complementation, we have expressed this SUPT3H construct, as well as the yeast-human chimeras described in the next section, beginning with the methionine codon at position 83 in the amino acid sequence. Expression of the human protein from the first methionine codon also did not complement in yeast.
To assess further the functional homology between S. cerevisiae Spt3 and SUPT3H, we constructed S. cerevisiae-human chimeric SPT3 genes and tested them for complementation of an spt3⌬ mutation. Each chimera (Fig. 3) also encoded an HA-1 epitope tag at the N-terminus. The results of expressing these chimeras in an spt3⌬ background is shown in Fig. 4 . Several of the chimeras either fully or partially complemented an spt3⌬ mutation. Among the chimeras with SUPTH3 sequences at the N-terminal end, the one containing the smallest number of human residues (chimera 1) was able to complement fully. Two other N-terminal human chimeras containing 109 or 143 human N-terminal residues (chimeras 2 and 3) also partially complemented an spt3⌬ mutation, resulting in a His ϩ Lys ϩ phenotype. Chimera 3, the longest N-terminal human chimera that could complement, contained 42% human SUPT3H amino acids. Surprisingly, these two N-terminal human chimeras (chimeras 2 and 3) that partially complemented the spt3⌬ mutation also caused a weak dominant Spt Ϫ phenotype in an SPT3 ϩ strain (data not shown). All other N-terminal human-yeast chimeras failed to complement. Among the chimeras with human sequences at the C-terminal end, only the two with the smallest amount of human sequences resulted in complementation (Fig. 4) . These human sequences are required for function as expressing the same 258 N-terminal amino acids of Spt3 without any human sequences is not sufficient for complementation.
To determine the level of protein produced for each chimera, immunoblot analysis was carried out (Fig.  5) . Only S. cerevisiae Spt3 and chimeras 10 and 11, which are mostly S. cerevisiae Spt3, were present at easily detectable levels. Thus, some of the chimeras may not complement due to lack of expression. Only a small level of expression may be required, as at least three of the N-terminal human chimeras showed at least partial complementation and yet little or no detectable protein was observed. Despite low levels of expression for some chimeras, the results of the chimera analysis suggest that human Spt3 has retained some Spt3 function and that there may be multiple functional domains in Spt3 that interact with other factors or that carry out some regulatory or catalytic function.
DISCUSSION
In this study we have identified a human homologue of S. cerevisiae Spt3. The sequence alignment of the predicted human protein with the previously identified Spt3   FIG. 3 . A summary of chimeric yeast-human fusions is presented schematically. Human residues are shown in black. S. cerevisiae residues are shown in white. The numbers at the left of the bars indicate the yeast and human residues included in each chimera. Each chimera included an HA-1 epitope tag at the N-terminus after the initiator methionine.
FIG. 4. spt3⌬ strains (FY294) containing the insertion mutations
his4-917␦ and lys2-173R2 were transformed with plasmids expressing yeast-human chimeras from the MET25 promoter. Transformants expressing these chimeras were spotted on SC-Leu plates and were replica plated to SD-Leu-Lys, SD-Leu-His, and SD-Leu. The numbers at the left of the spots indicate the corresponding chimera shown in Fig. 3. homologues from four different yeasts has shown that the human protein is conserved in the same three regions that are conserved among the yeast homologues (Madison and Winston, 1997b) . Functional analysis has shown that human Spt3 does not function in S. cerevisiae. This result may be caused by the low level of expression of the human protein in S. cerevisiae or by a functional difference between the yeast and human proteins. The result that human-yeast Spt3 chimeras are partially functional in S. cerevisiae strongly suggests that the transcriptional function performed by Spt3 has been at least partially conserved across species.
The human SPT3 homologue, SUPT3H was discovered in the course of positional cloning of the gene responsible for cleidocranial dysplasia (CCD). The identification of this gene in the CCD locus led us to screen for mutations in SUPT3H that were associated with CCD in patients. However, extensive analysis failed to detect a link between mutations in SUPT3H and the CCD phenotype (data not shown). Subsequently, another gene within the CCD locus was found to be mutated in CCD patients and is described elsewhere Otto et al., 1997) . Thus, SUPT3H is not the CCD gene.
Recent work has demonstrated that S. cerevisiae Spt3 is a member of a large protein complex, SAGA, that contains the histone acetyltransferase, Gcn5 (Grant et al., 1997; Roberts and Winston, 1997) . Genetic analysis suggests that, although these proteins are members of the same complex, they carry out different functions . Other analysis suggested that SAGA carries out roles in transcription that are partially overlapping with roles of two other large transcription complexes, RNA polymerase II holoenzyme and the Snf/Swi complex . Previous work had identified human homologues for two other members of this complex, Gcn5 and Ada2 (Candau et al., 1996) . The very recent discovery of a human complex that contains the histone acetyltransferase PCAF, SUPT3H, and human Ada proteins (Ogryzko et al., 1998) strongly suggests that these functions have been conserved between yeast and human.
FIG. 5.
Expression of chimeric yeast-human SPT3 genes in yeast. Extracts from strains containing HA-1 epitope tagged human yeast chimeras were prepared. Lanes 2-14 contain extract prepared from spt3⌬ strains expressing chimeras 1-11. 35 g of whole-cell extract from each strain was fractionated on a 12.5% SDS polyacrylamide gel, transferred to Immobilon, and then probed with anti-HA-1 antiserum to detect the proteins. Approximately equal loading between lanes was verified by Ponceau S staining of the membrane. rSpt3 in lane 15 is 240 ng of recombinant 6-histidine-HA-1-tagged Spt3 purified from Escherichia coli. Protein molecular weight standards are indicated at the left.
